Lilly asks FDA to approve blood thinner
Indianapolis drug company Eli Lilly and Co. and its development partner met their year-end deadline to submit blood thinner prasugrel for regulatory approval. Lilly and Daiichi Sankyo Co. Ltd. filed for U.S. Food and Drug Administration approval on Dec. 26, they announced today. Prasugrel could be a blockbuster if it successfully supplants the current best-selling […]